QTLs in Region (GRCm39)
| 13824979 | Epid1_m | epididymis and vas deferens weight 1 (mouse) | | | | | 4 | 89888237 | 99857197 | Mouse |
| 27226782 | Tibl2_m | tibia length 2, 5 week (mouse) | | | | | 4 | 90888237 | 111257197 | Mouse |
| 13824982 | Svwq1_m | seminal vesicle weight QTL 1 (mouse) | | | | | 4 | 89888237 | 118857197 | Mouse |
| 11532714 | Sluc43_m | susceptibility to lung cancer 43 (mouse) | | | | | 4 | 46642108 | 123127211 | Mouse |
| 13506251 | Cytrq1_m | cytokine response QTL 1 (mouse) | | | | | 4 | 65718086 | 99718086 | Mouse |
| 12904002 | Opfaq9_m | open field activity QTL 9 (mouse) | | | | | 4 | 92975790 | 126975790 | Mouse |
| 4141623 | W6q13_m | weight 6 weeks QTL 13 (mouse) | | | Not determined | | | 88982069 | 140468203 | Mouse |
| 25314312 | Syncl2_m | synaptonemal complex length 2 (mouse) | | | | | 4 | 65718237 | 146584457 | Mouse |
| 1357726 | Lnopy1_m | lens opacity 1 (mouse) | | | Not determined | | 4 | 85428838 | 119429037 | Mouse |
| 11532708 | Sluc43i_m | susceptibility to lung cancer 43i (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 11532707 | Sluc43h_m | susceptibility to lung cancer 43h (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 11532706 | Sluc43c_m | susceptibility to lung cancer 43c (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 27226770 | Tibl11_m | tibia length 11, 10 week (mouse) | | | | | 4 | 88518237 | 108357197 | Mouse |
| 11532705 | Sluc43b_m | susceptibility to lung cancer 43b (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 1302044 | Nss1_m | NOD Sjogren's syndrome 1 (mouse) | | | Not determined | | 4 | 71982069 | 105982216 | Mouse |
| 11532704 | Sluc43a_m | susceptibility to lung cancer 43a (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 14696687 | Gdq1_m | grooming duration QTL 1, males (mouse) | | | | | 4 | 96888237 | 111857197 | Mouse |
| 27226766 | Tibl17_m | tibia length 17, 16 week (mouse) | | | | | 4 | 88518237 | 108457197 | Mouse |
| 27226760 | Feml19_m | femur length 19, 16 week (mouse) | | | | | 4 | 90888237 | 108457197 | Mouse |
| 4141093 | W3q17_m | weight 3 weeks QTL 17 (mouse) | | | Not determined | | | 88982069 | 140468203 | Mouse |
| 1302031 | Bulb1_m | bulb size 1 (mouse) | | | Not determined | | 4 | 74033887 | 108034029 | Mouse |
| 27095939 | Ulnl9_m | ulna length 9, 16 week (mouse) | | | | | 4 | 65318237 | 118857197 | Mouse |
| 27095938 | Ulnl6_m | ulna length 6, 10 week (mouse) | | | | | 4 | 66718237 | 98588237 | Mouse |
| 11567249 | Elorr3_m | ethanol induced loss of righting response 3 (mouse) | | | | | 4 | 3722677 | 156268235 | Mouse |
| 12904933 | Edlmmq3_m | extensor digitorum longus muscle mass QTL 3 (mouse) | | | | | 4 | 81213991 | 115213991 | Mouse |
| 1301815 | Sles2_m | systemic lupus erythmatosus suppressor 2 (mouse) | | | Not determined | | 4 | 94957579 | 150676858 | Mouse |
| 1300918 | Stheal4_m | soft tissue heal 4 (mouse) | | | Not determined | | 4 | 89969627 | 123969747 | Mouse |
| 1301556 | Cd4vts1_m | CD4 virgin T cell subset 1 (mouse) | | | Not determined | | 4 | 85428838 | 119429037 | Mouse |
| 26884406 | Huml3_m | humerus length 3, 10 week (mouse) | | | | | 4 | 75618237 | 100157197 | Mouse |
| 1301823 | Bmd7_m | bone mineral density 7 (mouse) | | | Not determined | | 4 | 88982069 | 151654550 | Mouse |
| 27226801 | Feml6_m | femur length 6, 5 week (mouse) | | | | | 4 | 87518237 | 103257197 | Mouse |
| 1302204 | Spm1_m | splenomegaly modifier (mouse) | | | Not determined | | 4 | 82244395 | 116244582 | Mouse |
| 11532703 | Sluc43g_m | susceptibility to lung cancer 43g (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 11532702 | Sluc43f_m | susceptibility to lung cancer 43f (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 11532701 | Sluc43e_m | susceptibility to lung cancer 43e (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 1558948 | Ath8_m | atherosclerosis 8 (mouse) | | | Not determined | | 4 | 45658442 | 105156995 | Mouse |
| 11532700 | Sluc43d_m | susceptibility to lung cancer 43d (mouse) | | | | | 4 | 74444699 | 108444983 | Mouse |
| 11039517 | Ltpr4_m | Leishmania tropica response 4 (mouse) | | | | | 4 | 79365751 | 113365867 | Mouse |
| 11039504 | Ltpr4a_m | Leishmania tropica response 4a (mouse) | | | | | 4 | 79365751 | 113365867 | Mouse |
| 11039505 | Ltpr4c_m | Leishmania tropica response 4c (mouse) | | | | | 4 | 79365751 | 113365867 | Mouse |
| 1301930 | Papg1_m | pulmonary adenoma progression 1 (mouse) | | | Not determined | | 4 | 85781167 | 119781279 | Mouse |
| 1357870 | Pfat1_m | predicted fat percentage 1 (mouse) | | | Not determined | | 4 | 63619526 | 97619685 | Mouse |
| 1302057 | Pgia27_m | proteoglycan induced arthritis 27 (mouse) | | | Not determined | | 4 | 70067227 | 104067464 | Mouse |
| 1301545 | Gauc_m | glucose area under curve (mouse) | | | Not determined | | 4 | 76763107 | 110763305 | Mouse |
| 11039506 | Ltpr4b_m | Leishmania tropica response 4b (mouse) | | | | | 4 | 79365751 | 113365867 | Mouse |
| 13208562 | Wght7_m | weight 7 (mouse) | | | | | 4 | 90888237 | 148084457 | Mouse |
| 27226787 | Feml14_m | femur length 14, 10 week (mouse) | | | | | 4 | 84918237 | 107157197 | Mouse |
| 10412193 | Plep_m | plasma lepin levels (mouse) | | | Not determined | | 4 | 74444699 | 108444983 | Mouse |
| 27095900 | Scvln9_m | sacral vertebrae length 2, 10 week (mouse) | | | | | 4 | 68018237 | 107157197 | Mouse |
| 39128212 | Lwq21_m | liver weight QTL 21 (mouse) | | | | | 4 | 88982069 | 140468203 | Mouse |
| 27226716 | Metcl2_m | metatarsal-calcaneal length 2, 5 week (mouse) | | | | | 4 | 88118237 | 118557197 | Mouse |
| 26884445 | Sklq7_m | skull length QTL 7, 10 week (mouse) | | | | | 4 | 68018237 | 150884457 | Mouse |
| 26884434 | Zlq1_m | zygomatic length QTL 1, 5 week (mouse) | | | | | 4 | 53700000 | 103257197 | Mouse |
| 26884435 | Zlq4_m | zygomatic length QTL 4, 10 week (mouse) | | | | | 4 | 85118237 | 104957197 | Mouse |
| 1300697 | Sle2_m | systemic lupus erythmatosus susceptibility 2 (mouse) | | | Not determined | | 4 | 77957579 | 111957775 | Mouse |
| 1301597 | Anxty_m | anxiety (mouse) | | | Not determined | | 4 | 74137574 | 128009280 | Mouse |
| 26884437 | Sklq13_m | skull length QTL 13, 16 week (mouse) | | | | | 4 | 57700000 | 155684457 | Mouse |
| 4141549 | W10q10_m | weight 10 weeks QTL 10 (mouse) | | | Not determined | | | 88982069 | 140468203 | Mouse |
| 1357895 | Ctrcts_m | cataract severity (mouse) | | | Not determined | | 4 | 45709925 | 138342753 | Mouse |
| 26884431 | Zlq8_m | zygomatic length QTL 8, 16 week (mouse) | | | | | 4 | 74718237 | 108357197 | Mouse |
| 12879903 | Berr8_m | berghei resistance locus 8 (mouse) | | | | | 4 | 64222460 | 98222460 | Mouse |
| 12879897 | Berr4_m | berghei resistance locus 4 (mouse) | | | | | 4 | 71982069 | 105982216 | Mouse |
| 4142047 | Mvwf3_m | modifier of von Willebrand factor 3 (mouse) | | | Not determined | | | 14010457 | 117072206 | Mouse |
| 1301233 | Sbw2_m | splenomegaly-NZB x NZW 2 (mouse) | | | Not determined | | 4 | 94957579 | 128009280 | Mouse |
| 27226746 | Metcl8_m | metatarsal-calcaneal length 8, 10 week (mouse) | | | | | 4 | 87518237 | 107157197 | Mouse |
| 27095924 | Pglq2_m | pelvic girdle length QTL 2, 5 week (mouse) | | | | | 4 | 69118237 | 130727311 | Mouse |
| 27095927 | Pglq7_m | pelvic girdle length QTL 7, 10 week (mouse) | | | | | 4 | 88118237 | 108357197 | Mouse |
| 27095921 | Pglq12_m | pelvic girdle length QTL 12, 16 week (mouse) | | | | | 4 | 83118237 | 108357197 | Mouse |
| 27226739 | Metcl14_m | metatarsal-calcaneal length 14, 16 week (mouse) | | | | | 4 | 87518237 | 108357197 | Mouse |
| 1357561 | Mbsyd_m | metabolic syndrome (mouse) | | | Not determined | | 4 | 66888445 | 100888588 | Mouse |
| 1301118 | Bbaa23_m | B.burgdorferi-associated arthritis 23 (mouse) | | | Not determined | | 4 | 85781167 | 119781279 | Mouse |
| 11532738 | Abd1_m | autoimmune biliary disease 1 (mouse) | | | | | 4 | 88982069 | 116271120 | Mouse |
| 15039368 | Nmrs19_m | NAFLD-associated magnetic resonance shift 19 (mouse) | | | | | 4 | 90882780 | 124882780 | Mouse |
| 1301757 | Tlsr4_m | thymic lymphoma suppressor region 4 (mouse) | | | Not determined | | 4 | 66757130 | 100757258 | Mouse |
| 27095917 | Scvln14_m | sacral vertebrae length 2, 16 week (mouse) | | | | | 4 | 68018237 | 130277062 | Mouse |
| 1301731 | Cafq2_m | caffeine metabolism QTL 2 (mouse) | | | Not determined | | 4 | 94732255 | 128732454 | Mouse |
| 4141900 | Skts-fp1_m | skin tumor susceptibility in FVB and PWK 1 (mouse) | | | Not determined | | 4 | 53550839 | 124055180 | Mouse |
| 1300966 | Pabr2_m | plasma apolipoprotein B (human) regulator 2 (mouse) | | | Not determined | | 4 | 46332646 | 105801860 | Mouse |
| 1301739 | Pitm2_m | prion incubation time 2 (mouse) | | | Not determined | | 4 | 71982069 | 105982216 | Mouse |
| 1301867 | Idd11_m | insulin dependent diabetes susceptibility 11 (mouse) | | | Not determined | | 4 | 83604870 | 117605006 | Mouse |
| 26884449 | Sklq2_m | skull length QTL 2, 5 week (mouse) | | | | | 4 | 36700000 | 128993793 | Mouse |
| 27226724 | Tibw2_m | tibia width 2, proximal, 10 week (mouse) | | | | | 4 | 43000000 | 108357197 | Mouse |
| 27095905 | Scvln3_m | sacral vertebrae length 2, 5 week (mouse) | | | | | 4 | 55600000 | 128993793 | Mouse |
| 11553870 | Cmmm_m | carcinoma modifier of MSM (mouse) | | | | | 4 | 90590668 | 124590781 | Mouse |
